Founded in 2014, Guangzhou Junmu Biotechnology Co., Ltd. is a high-tech enterprise integrating pharmaceutical research and development, biotechnology services (raw and auxiliary material production) and marketing. The company strictly follows the ISO9001 and CNAS management system for product quality management, and passed the on-site inspection of the China Institute for Food and Drug Control in 2088 and officially became a supplier of reference materials and raw materials.
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>This compound is a modified nucleoside analog featuring an acetylated ribose moiety attached to an amino-triazine base. Synthesized via glycosylation and selective acetylation, its molecular formula is <strong>C9H12N4O5</strong>. The CAS number for this specific derivative is 101673-86-9.</p>
<h3>Application</h3>
<ul>
<li><strong>Medicinal Chemistry:</strong> Used as a key intermediate in the synthesis of antiviral agents targeting RNA polymerase.</li>
<li><strong>Research Reagents:</strong> Employed in biochemical assays to study nucleotide metabolism pathways.</li>
<li><strong>Pharmaceutical Development:</strong> Serves as a precursor for novel triazine-based therapeutics.</li>
</ul>
<h3>Precautions</h3>
<p>Store under inert atmosphere at -20°C to prevent hydrolysis. Handle with appropriate PPE due to potential mutagenicity. Not approved for direct clinical use without further formulation.</p>